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?Lyme Disease in Australia— Still To Be Proven! 
To the Editor: The first case of a syndrome
consistent with Lyme disease was reported from the
Hunter Valley region of New South Wales (NSW) in
southeastern Australia in 1982, but there was no
confirming serology. More clinical cases, again with-
out serologic confirmation, were reported in 1986,
two from the south coast and one from the central
coast of NSW. The Queensland State Health Labo-
ratories reported that 186 (14.9%) of 1,247 sera
taken from patients between 1986-1989 showed
antibody response to Borrelia burgdorferi of ³ 64 by
indirect fluorescence antibody test (IFAT), but none
of these results were confirmed by immunoblotting.
In 1988, a multidisciplinary investigation of pu-
tative Lyme disease began, encompassing clinical,
serologic, vector, and reservoir host studies, and
results from these studies have been published (1).
What follows herein is derived from the accumu-
lated published and unpublished data of the re-
search team, the members of which are credited in
the acknowledgments.
Over the past 6 years, principally because of local
publicity, there has been an increase in serologic
testing for Lyme disease in Australia, particularly
in southeastern Australia. Testing has often been
initiated by patients with undiagnosed health prob-
lems. Thus, most Lyme disease patients seen by
infectious disease specialists are self selected and
are referred for assessment on the basis of tick
exposure and reported positive serologic test results
for Lyme disease.
Patients with positive serologic test results fre-
quently have long-standing symptoms for which no
other diagnosis has been established. The most com-
mon symptoms are musculoskeletal, including my-
algias and arthralgias without objective evidence of
joint swelling, and syndromes involving fatigue and
loss of energy resembling chronic fatigue syndrome.
Some patients fulfill diagnostic criteria for fibromy-
algia. The next most common symptoms are neuro-
logical, and include frequent headaches, inability to
concentrate, and memory loss. The most common
dermatologic manifestation of chronic Lyme disease,
acrodermatitis chronica atrophicans, seen occasion-
ally in Europe and rarely in the United States, has
not been reported from Australia.
A few cases of erythema migrans, the charac-
teristic dermatologic manifestation of acute Lyme
disease, have been reported from southeastern Aus-
tralia, but clinical diagnosis can be confounded by
hypersensitivity reactions to tick bite; a spectacular
erythematous reaction is often associated with the
bite of Ixodes holocyclus, the most common tick
biting humans in NSW. Only eight specimens sub-
mitted to our laboratory included skin biopsies done
to isolate spirochetes. B. burgdorferi  s.l. was iso-
lated from one patient returning from Europe, but
no spirochetes were isolated from local patients.
In our serologic diagnostic service, an enzyme-
linked immunosorbent assay (ELISA) for IgG and
an IFAT for IgG and IgM have been used with
antigens derived from North American B. burgdor-
feri strain B31 (2). From 1988 to April 1994, 78
(1.8%) of 4,372 local patients were positive for IgG
by both methods. All 78 patients were tested by IgG
Western blot for confirmation by using the virulent
North American B. burgdorferi strain 297 and a
German strain designated B7: with B. burgdorferi
strain 297, 46 patient samples showed as many as
four indicative bands; with the European strain B7,
22 patient samples showed as many as three indica-
tive bands; bands used were 18, 21, 28, 30, 31, 34,
39, 41, 45, 58, 66, 83, and 93 kDa, modified from
Dressler et al (3). Twenty-four other patients with
various bacterial, viral, or autoimmune syndromes
not relating to Lyme disease were tested as controls:
with strain 297, 11 control samples showed as many
as two indicative bands, and with strain B7, 10
control samples showed as many as two indicative
bands.
A high degree of cross-reactivity was demon-
strated with the controls, particularly with respect
to the 31, 41, 58, and 66 kDa bands for both the
European and the American antigen. As none of the
78 patients, including putative late-stage patients
positive by ELISA and IFAT, showed more than four
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sidered negative by the criteria of Dressler et al (3).
Fewer than 1% of all referred patients conformed
with the national surveillance case definition used
in the United States by the Centers for Disease
Control and Prevention. Problems of specificity and
sensitivity associated with serologic testing for
Lyme disease are well recognized, particularly in
Australia where no local spirochete has been iso-
lated for use as a reference antigen.
Seroprevalence rates for B. burgdorferi infection
in humans have been compared between 200 high
(rural residents) and 200 low (urban residents) tick
exposure groups in coastal NSW, by using the IgG
ELISA. No significant difference was found between
the two groups, and the overall seropositivity rate
was 2.2% (9/400). A parallel survey of dogs in NSW
has shown a similar result with an overall seroposi-
tivity rate of 2.5% (6/239). These results contrast
with those reported from known endemic-disease
areas outside Australia that have rural populations
with considerably higher seropositive rates. The low
rate found by our surveys is similar to that found by
other studies undertaken in areas where Lyme dis-
ease is not endemic, and humans have 1%-3% posi-
tive serologic results cause by cross-reacting
antibodies (4).
From January 1990 to December 1992, ticks were
collected in areas associated with putative Lyme
disease cases and were examined for spirochetes to
detect a possible causative agent in potential vec-
tors. Ticks were collected along the east coast of
Australia, from southern Queensland through NSW
into northern Victoria, by flagging in natural habi-
tats, and from domestic and other native animals.
Detection of spirochetes was attempted by dark-field
microscopy and culturing of gut contents and by
direct testing of ticks using polymerase chain reac-
tion (PCR) to detect the Borrelia-specific flagellin
gene (5).
In total, more than 12,000 (>1,000 by PCR) ticks
were processed, including 7,922 I. holocyclus (1). No
spirochetes were detected by dark-field microscopy
or by PCR. Spirochete-like objects (SLOs), were ob-
served in 94 cultures from bloodfed ticks and only in
cultures with bacterial contaminants, presumably
from the bloodmeal. Some SLOs yielded positive
fluorescence results when tested with Borrelia-spe-
cific polyclonal antibodies, but tests with monoclonal
antibodies (anti-flagellin H9724, anti-OspA H5332,
anti-OspB H6831) were negative. Electron mi-
crographs showed that the SLOs were not typical of
Borrelia, were composed of fibers, and probably were
not spirochetes. The electron micrographs were
similar to micrographs of SLOs recovered from con-
taminated cultures from ticks in the United States
and Europe and thought to be composed of aggrega-
tions of bacterial flagella, probably from the con-
taminants. Molecular characterization indicated
that the SLOs were not related to B. burgdorferi.
A small number of native vertebrate animals (13
native rats Rattus fuscipes, 3 bandicoots Perameles
nasuta, and 1 marsupial mouse Antechinus stuartii)
trapped on the south coast of NSW were sampled by
ear-punch biopsy (6) for culture and PCR investiga-
tion, but no evidence of borreliae was found. The
animal sample was clearly inadequate, and the PCR
primers used for the tick and animal studies may
have been inappropriate and unable to identify na-
tive Australian spirochetes; however the extensive
investigations of tick gut contents by culturing and
dark field microscopy were also negative for borre-
liae.
There are some major differences between Austra-
lia and the Lyme-disease-endemic areas of the North-
ern Hemisphere with respect to the natural history of
borreliosis. No ticks of the I. persulcatus complex, the
principal vectors to humans in the northern hemi-
sphere, occur in Australia. In eastern Australia, the
logical candidate vector would be I. holocyclus,
which has a wide host range and is the most common
tick biting humans. I. holocyclus cannot transmit a
North American strain of B. burgdorferi (7) but the
association with any possible Australian spirochetes
remains unresolved. Likewise, none of the mammal
species identified as reservoir hosts in the Northern
Hemisphere are present in Australia. There are
reports of spirochetes in Australian native animals,
and a local mammal could be a reservoir host for an
indigenous spirochete that occasionally infects hu-
mans through a tick vector and produces a clinical
syndrome similar to Lyme disease; however, no spi-
rochete was detected in the ticks or animals studied.
The diagnosis of Lyme disease outside known
disease-endemic areas should not be based solely on
serology because unrelated syndromes, such as
autoimmune diseases and cross reactions with other
bacteria, can produce false-positive results. Like-
wise, a definitive diagnosis on clinical grounds alone
in a nonendemic-disease area is difficult to justify
without adequate scientific support based on isola-
tion of the causative agent from the patient or from
another patient or known vector from the region. In
Australia, disagreement as to what constitutes a
positive serologic result has additionally contrib-
uted to overdiagnosis of Lyme disease. Until an
organism is isolated from a local patient and is
characterized, the presence of Lyme disease in Aus-
tralia will remain controversial.
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A Novel Morbillivirus Pneumonia of Horses and
its Transmission to Humans
To the editor:  On September 22 and 23, 1994,
veterinary authorities in Queensland and at the
CSIRO Australian Animal Health Laboratory were
advised of an outbreak of acute respiratory disease
in horses at a stable in the Brisbane suburb of
Hendra. The trainer of the horses had been hospi-
talized for a respiratory disease and was in critical
condition. At that time, the cause of the horses’
illness was unclear and any link between equine and
human disease was thought improbable. Poisoning,
bacterial, viral, and exotic disease causes were in-
vestigated. The history of the horses on this property
was considered important (Figure 1). Two weeks
before the trainer’s illness, on September 7, two
horses had been moved to the Hendra stable from a
spelling paddock in Cannon Hill (6 km). One of
these, a pregnant mare, was sick and died within 2
days. The other horse was subsequently moved on
and never became sick. By September 26, 13 horses
had died: the mare; 10 other horses in the Hendra
stable; one horse, which had very close contact with
horses in the Hendra stable, on a neighboring prop-
erty; and one which had been transported from the
stable to another site (150 km). Four Hendra horses
and three others (one in an adjacent stable, one
moved to Kenilworth, and one to Samford) were
later considered to have been exposed and recovered
from the illness. Some of these horses were asymp-
tomatic. Nine Hendra horses have remained unaf-
fected. The sick horses were anorexic, depressed,
usually febrile (temperature up to 41°C), showed
elevated respiratory rates, and became ataxic. Head
pressing was occasionally seen, and commonly, a
frothy nasal discharge occurred before death.
On September 14, a stablehand at the Hendra
stable developed an influenza-like illness charac-
terized by fever and myalgia. The next day, the horse
trainer also became ill with similar symptoms. Both
had close contact with the dying mare, particularly
the trainer who was exposed to nasal discharge
while trying to feed her; he had abrasions on his
hands and arms. The stablehand, a 40-year-old man,
remained ill for 6 weeks and gradually recovered.
Besides myalgia, he also had headaches, lethargy,
and vertigo. The trainer, a 49-year-old man, was a
heavy smoker and showed signs consistent with
Legionella infection. He ultimately required venti-
lation for respiratory distress and died after 6 days
(Selvey L, et al. A novel morbillivirus infection caus-
ing severe respiratory illness in humans and horses,
submitted).
At the beginning of the diagnostic investigation
in horses, African horse sickness, equine influenza,
and hyperacute equine herpes virus were excluded
as possible causes by antigen  trapping enzyme-
linked immunosorbent assay (ELISA), polymerase
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